Lenalid 25 Mg
- Manufacturer : Natco Pharma Ltd
- Equivalent Brands : Revlimid
- Generic Brands : Lenalidomide
Lenalid 25mg Capsule is used to treat anemia, which occurs in patients suffering from myelodysplastic syndrome (MDS). The drug is used in combination with certain other medicines in the treatment of multiple myeloma (MM).
Some patients suffering from mantle cell lymphoma (MCL) may also receive Lenalid 25Mg Capsule treatment, as it is an immunomuodulator.
Lenalidomide is used in adults in combination with other medicines to treat multiple myeloma (a type of cancer which affects plasma cells, a certain type of white blood cell) and alone to treat myelodysplastic syndromes (collection of many different blood and bone marrow diseases).
It is also used to treat mantle cell lymphoma (aggressive variety of cancer that occurs in lymph nodes).
Lenalid 25mg Capsule should not be taken if your body is hypersensitive to any substance present in it. Moreover, the drug can harm a fetus, thus it should not be used by women who are expecting or those trying to conceive a child.
Breast feeding mothers should consult their medical providers before starting Lenalid 25mg Capsule.
The drug is mean to be taken orally, either with food or without. Swallow the entire capsule with the help of some water. It is best that you do not chew or break the capsule, as it will become less effective.
Like all medicines, Lenalid 25mg Capsule too leads to some side effects such as pain in the abdomen, infection of the upper respiratory tract or the urinary tract, dizziness, constipation, diarrhea, cough, edema, fatigue, muscle cramps, nausea etc.
If these side effects do get worse, get in touch with your health care provider and seek relevant treatment.
Lenalidomide has been used to successfully treat both inflammatory disorders and cancers in the past 125 years. There are multiple mechanisms of action, and they can be simplified by organizing them as mechanisms of action in vitro and in vivo.
In vitro, cheap lenalidomide has three main activities: direct anti-tumor effect, inhibition of the microenvironment support for tumor cells, and immunomodulatory role.
In vivo, lenalidomide induces tumor cell apoptosis directly and indirectly by inhibition of bone marrow stromal cell support, by anti-angiogenic and anti-osteoclastogenic effects, and by immunomodulatory activity.Lenalidomide has a broad range of activities that can be exploited to treat many hematologic and solid cancers.
Multiple Myeloma: Lenalidomide in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM) who have received at least one prior therapy.
Myelodysplastic Syndromes: Lenalidomide is indicated for the treatment of patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 25q cytogenetic abnormality with or without additional cytogenetic abnormalities.
Mantle Cell Lymphoma: Lenalidomide is indicated for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
Immediately proceed to your nearest emergency department if you suffer an allergic reaction. Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives.
Lenalid is not always suitable for all patients. Always consult your health care provider prior to using this medication if you are pregnant, breastfeeding, trying to conceive, using any other medication (prescription or non-prescription), using any herbal products or supplements, or if you have any allergies or other health problems.
The correct dosage and prescription commonly depend on the patient and the condition being treated. Do not adjust your dosage without the approval of your health care provider. This product is only for use as prescribed and instructed.
Before taking Lenalid (Lenalidomide) you must tell your physician if you are receiving dialysis, have a tumor, cancer, or kidney problems.
It is extremely important that women do not become pregnant while taking this drug as it can cause birth defects in unborn children. It can also be passed on through sexual intercourse with a man who is taking the medication. Make sure to always use precautions when having sexual intercourse with pregnant women when taking this drug.
Always follow the instructions of doctor regarding the dosage and duration. Multiple Myeloma and mantle cell lymphoma: 225 mg/day on days 1 through 21 of repeated 28 day cycles.
Myelodysplastic Diseases: 10 mg once daily. This information is not intended as medical advice for individual conditions or treatment.
It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen.
Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
Lenalid is usually taken in a 28 day cycle, taking the medication once daily or as directed by a doctor. The capsules can be taken with or without food but should be taken with a full glass of water.
Lenalid can be used alone or in combination with other medication to treat anemia associated with myelodysplastic syndromes and multiple myeloma. Contact a doctor for the correct dosage as it will depend on the patients condition and their reaction to the medication. The capsules should be taken whole and not broken, crushed, chewed or opened.
The active ingredient lenalidomide is considered an immunomodulating agent. The medication affects the way the immune system works to help produce normal blood cells while killing abnormal cells in the bone marrow.
Lenalid (Lenalidomide) at room temperature, 259o to 86oF (125oF to 30o C).